ORCU:NASDAQDirexion Daily ORCL Bull 2X ETF Analysis
Data as of 2026-05-19 - not real-time
$14.57
Latest Price
8/10Risk
Risk Level: High
Executive Summary
ORCU is trading at $14.57, just above its 20‑day SMA of $14.16 but still below the 200‑day SMA of $14.41, indicating a modest short‑term upside bias. The 14‑day RSI sits at 54.6, suggesting neutral momentum without clear overbought pressure. However, the MACD histogram is slightly negative and the signal line is flagged as bearish, pointing to a potential short‑term pullback. Volatility is extreme at 118% over the past 30 days, and the fund’s beta of 3.65 amplifies any moves in Oracle’s underlying stock. The fund has already suffered a -39.8% YTD decline and a historic max drawdown of -67.9%, underscoring the erosion risk inherent in leveraged products.
With a 0.97% expense ratio and daily reset mechanics, the tracking error appears nominal but the long‑term compounding drag can be severe. Liquidity is moderate; recent volume (~0.9 M) trails the 10‑day average of 1.68 M, and the ETF’s market cap is not disclosed, raising execution concerns near the $10.98 support level. The broader market sentiment is in “Extreme Greed” (Fear & Greed Index 89), which can mask underlying volatility in high‑beta leveraged ETFs. Given these factors, the fund presents a high overall risk profile and is best approached with a short‑term tactical lens rather than a buy‑and‑hold strategy. Investors should monitor the $16.90 resistance zone and the stability of Oracle’s earnings outlook before considering any re‑entry.
With a 0.97% expense ratio and daily reset mechanics, the tracking error appears nominal but the long‑term compounding drag can be severe. Liquidity is moderate; recent volume (~0.9 M) trails the 10‑day average of 1.68 M, and the ETF’s market cap is not disclosed, raising execution concerns near the $10.98 support level. The broader market sentiment is in “Extreme Greed” (Fear & Greed Index 89), which can mask underlying volatility in high‑beta leveraged ETFs. Given these factors, the fund presents a high overall risk profile and is best approached with a short‑term tactical lens rather than a buy‑and‑hold strategy. Investors should monitor the $16.90 resistance zone and the stability of Oracle’s earnings outlook before considering any re‑entry.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD signal and negative histogram
- Extreme 30‑day volatility and high beta
- Price near support at $10.98 with limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Daily reset decay erodes returns over time
- Neutral RSI and price above short‑term SMA
- Expense ratio near 1% reduces net performance
Long Term
> 3 yearsCautious
Model confidence: 9/10
Key Factors
- Leveraged structure unsuitable for long horizons
- Historical max drawdown of -67.9% illustrates tail risk
- Compounding drag from 0.97% expense and daily reset
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.97%
AUM$46.9M
Inception Date2025-11-19
Avg Daily Volume1,680,530
Premium/Discount0.00%
Tracking Error0.00%
Technical Analysis
TrendNeutral
RSI54.7
Support$10.98
Resistance$16.90
MA 20$14.16
MA 50$11.89
MA 200$14.41
MACDBearish
VolumeStable
Fear & Greed Index89.23
Risk Assessment
Beta3.65
Volatility118.73%
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.